38 results
Keyword Selincro Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Selincro
Nalmefene hydrochloride dihydrate, Alcohol-Related Disorders
Date of authorisation: 24/02/2013, Revision: 13, Authorised, Last updated: 17/05/2022Selincro Chemically-Induced Disorders Substance-Related … assessment report (EPAR) for Selincro. It explains how the Committee … the conditions of use for Selincro. What is Selincro? Selincro is medicine that contains … -
List item
Press release: European Medicines Agency recommends approval of medicine for reduction of alcohol consumption
Last updated: 14/12/2012Selincro offers treatment in conjunction … reduction of alcohol consumption Selincro offers treatment in conjunction … marketing authorisation for Selincro, a medicinal product intended … -
List item
National expert: Antero Kallio, Finnish Medicines Agency (updated)
- Declaration of interests - 81.4 KB | PDF
- Curriculum Vitae - 20.06 KB | PDF
Therapies Corp. Lead role Selincro Alcohol dependence 05/1988-01/1995 … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 December 2012
CHMP, Last updated: 14/12/2012Selincro INN nalmefene Marketing-authorisation … -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 22/06/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 November 2013
European Medicines Agency, London, UK, from 04/11/2013 to 07/11/2013, Last updated: 02/07/2012 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2016
European Medicines Agency, London, UK, from 20/06/2016 to 23/06/2016, Last updated: 06/01/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 June 2013
European Medicines Agency, London, UK, from 10/06/2013 to 13/06/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 June 2015
European Medicines Agency, London, UK, from 08/06/2015 to 11/06/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 March 2014
European Medicines Agency, London, UK, from 03/03/2014 to 06/03/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2015
European Medicines Agency, London, UK, from 09/03/2015 to 12/03/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 January 2018
European Medicines Agency, London, UK, from 08/01/2018 to 11/01/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 March 2017
European Medicines Agency, London, UK, from 06/03/2017 to 09/03/2017, Last updated: 06/03/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 September 2014
European Medicines Agency, London, UK, from 08/09/2014 to 11/09/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
European Medicines Agency, London, UK, from 25/09/2017 to 29/09/2017, Last updated: 06/09/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 September 2015
European Medicines Agency, London, UK, from 07/09/2015 to 10/09/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August - 2 September 2016
European Medicines Agency, London, UK, from 30/08/2016 to 02/09/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 27/09/2021 to 30/09/2021, Last updated: 27/02/2018 -
List item
Press release: European Medicines Agency publishes 2012 annual report
Last updated: 16/04/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 September 2018
European Medicines Agency, London, UK, from 03/09/2018 to 06/09/2018, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 June 2017
European Medicines Agency, London, UK, from 19/06/2017 to 22/06/2017, Last updated: 06/01/2014 -
List item
Annual reports and work programmes (updated)
Last updated: 10/06/2022